Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Kankuri

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Alimentary Pharmacology & Therapeutics|May 11, 2005
Probiotic supplementation improves tolerance to Helicobacter pylori eradication therapy--a placebo-controlled, double-blind randomized pilot studyE Myllyluoma, L Veijola, T Ahlroos, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 16, 2001
Suppression of acute experimental colitis by a highly selective inducible nitric-oxide synthase inhibitor, N-[3-(aminomethyl)benzyl]acetamidineE Kankuri, K Vaali, R G Knowles, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 17, 2007
Probiotic intervention decreases serum gastrin-17 in Helicobacter pylori infectionE Myllyluoma, K Kajander, H Mikkola, et al.
Experimental & Molecular Medicine|April 3, 2023
Altered acylcarnitine metabolism and inflexible mitochondrial fuel utilization characterize the loss of neonatal myocardial regeneration capacityE Kankuri, P Finckenberg, J Leinonen, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Alimentary Pharmacology & Therapeutics|May 11, 2005
Probiotic supplementation improves tolerance to Helicobacter pylori eradication therapy--a placebo-controlled, double-blind randomized pilot studyE Myllyluoma, L Veijola, T Ahlroos, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 16, 2001
Suppression of acute experimental colitis by a highly selective inducible nitric-oxide synthase inhibitor, N-[3-(aminomethyl)benzyl]acetamidineE Kankuri, K Vaali, R G Knowles, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 17, 2007
Probiotic intervention decreases serum gastrin-17 in Helicobacter pylori infectionE Myllyluoma, K Kajander, H Mikkola, et al.
Experimental & Molecular Medicine|April 3, 2023
Altered acylcarnitine metabolism and inflexible mitochondrial fuel utilization characterize the loss of neonatal myocardial regeneration capacityE Kankuri, P Finckenberg, J Leinonen, et al.
Pageof 2